Group items tagged

Siemens Healthineers has signed a definitive agreement to acquire all fully diluted shares of US-based Corindus Vascular Robotics. The deal is valued at $4.28 per share in cash or $1.1bn in total. Corindus develops, produces and sells robotic systems for minimally invasive procedures, while Siemens' products use quality imaging before and during medical interventions to make minimally invasive treatment possible.

AvoColor is derived from the seed of the avocado and represents a disruptive innovation in "natural"food colors, as no other alternative shares its unique..

AvoColor is derived from the seed of the avocado and represents a disruptive innovation in "natural"food colors, as no other alternative shares its unique..

World Health Organization (WHO) considering need of safety of food launched 'free from microbes, viruses and chemicals' as a theme for this world Health day. Health services in India shared that ev...

Psychiatry specialist, Dr. Hryhorowych, shares his experience with CureMD. He found the process of shifting to CureMD from his previous billing company uncomplicated. Watch him talk about how CureMD's end-to-end revenue cycle management (http://bit.ly/1uzfXzV) helped him take back control of his billing. Read more http://www.curemd.com/testimonials.asp

Among the gene type, antigen dominates the overall market accounting for two-ninths of the total share in 2016. Among the applications, oncological disorders is the largest contributor towards the market growth.

The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.

Report provides an extensive analysis of the current and emerging market trends and dynamics in the global refurbished medical equipment market.

This study evaluates the competitive landscape and value chain that helps in understanding the competitive environment across the geographies.

study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.

Global laparoscopic instruments market size, share, market intelligence, company profiles, market trends, growth, strategy, research and analysis, forecast 2018-2023

Global pen needle market size, share, market intelligence, company profiles, market trends, growth, strategy, research and analysis, forecast 2018-2023

Global pen needle market, size, share, market trends, research and analysis report by type (standard pen needles, safety pen needles) by therapy (insulin, Glp-1, growth hormones) forecast 2018-2023

Search healthcare & medical job types on a full-time/Permanent, part-time/ Temporary, fellowship, contract, partnership/revenue sharing, visiting consultant, traveling nurse, Locum, Home-care nurse, Researcher, fellowships, internship.

To more detail visit www.perzue.com

Immunodiagnostics occupied the highest share of the market in 2016 and is expected to maintain the lead during the forecast period owing to the introduction of novel reagents and an increase in R&D. UK IVD market accounted for $ 2,148 million in 2016 and is estimated to reach $3,127 million by 2023, growing at a CAGR of 5.4%

Global Computed Tomography Market- Market Size, Growth, Trends, Competitive analysis, End-user analysis, Market Share analysis, Forecast 2018-2025

The global immunotherapy drugs market will continue to grow, owing to increasing incidence of lifestyle-related and chronic disease globally, increasing product approvals, rising healthcare expenditures, and increasing access to better diagnostic & treatment facilities. High preference for immunotherapy over traditional chemotherapy and its use in combination with the same in first-line treatments coupled with high adoption of targeted therapies is expected to support the market growth during the forecast period 2019-2025. The immunotherapy drugs market, by type of drug, is segmented into monoclonal antibodies (mAbs), vaccine, non-specific immunotherapies, adaptive cell therapy, and others. Among these, monoclonal antibodies occupied a significant share in 2018 while the fastest growing type was adaptive cell therapy, which is expected to grow at a high CAGR during the forecast period 2019-2025. Increased preference for mAbs with fewer side-effects made this type the dominant market shareholder in 2018.

Global drug discovery services market will continue to grow, owing to upsurge in externalization of R&D activities, rising expenditure on R&D, and increasing incidence of chronic diseases. Expiration of patents boosting the demand for drug discovery and the introduction of innovative drug discovery technologies are projected to support the market growth during the forecast period 2019-2025. The global drug discovery services market, by type, is segmented into medicinal chemistry services, biology services, and pharmacokinetics and drug metabolism. Among these, the medicinal chemistry services segment accounted for the largest share in 2018 and is expected to grow at a high-double-digit CAGR by 2025. Increasing tendency of pharma companies to externalize discovery & development services, upsurge in the number of drug discovery & development activities, and growing R&D expenditure are the key factors driving the growth of the segment.

By application, the gynecology surgery segment accounted for the highest share in 2019. However, orthopedic surgery is expected to register the highest CAGR during the forecast period owing to large patient population undergoing robotic surgical procedures, lesser healing time and comparatively less post-surgical complications.